Invesco’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240M Buy
4,588,706
+910,047
+25% +$54.6M 0.02% 631
2025
Q4
$216M Sell
3,678,659
-267,369
-7% -$16.2M 0.02% 649
2025
Q3
$220M Buy
3,946,028
+283,303
+8% +$15.2M 0.03% 631
2025
Q2
$188M Sell
3,662,725
-527,390
-13% -$26.5M 0.03% 656
2025
Q1
$246M Buy
4,190,115
+369,651
+10% +$25.1M 0.05% 518
2024
Q4
$275M Buy
3,820,464
+358,756
+10% +$26.3M 0.05% 486
2024
Q3
$277M Buy
3,461,708
+311,069
+10% +$23.4M 0.05% 472
2024
Q2
$226M Buy
3,150,639
+23,923
+0.8% +$1.76M 0.05% 514
2024
Q1
$220M Buy
3,126,716
+150,823
+5% +$10.8M 0.05% 543
2023
Q4
$230M Buy
2,975,893
+1,095,081
+58% +$72.1M 0.05% 487
2023
Q3
$128M Buy
1,880,812
+241,771
+15% +$19.1M 0.03% 643
2023
Q2
$134M Sell
1,639,041
-387,532
-19% -$31.2M 0.04% 623
2023
Q1
$150M Buy
2,026,573
+185,104
+10% +$14.3M 0.04% 573
2022
Q4
$153M Buy
1,841,469
+85,457
+5% +$6.79M 0.04% 564
2022
Q3
$125M Sell
1,756,012
-203,964
-10% -$17.6M 0.04% 587
2022
Q2
$170M Buy
1,959,976
+40,232
+2% +$3.77M 0.05% 482
2022
Q1
$208M Sell
1,919,744
-39,872
-2% -$4.11M 0.05% 476
2021
Q4
$253M Buy
1,959,616
+148,600
+8% +$18.2M 0.06% 422
2021
Q3
$219M Sell
1,811,016
-486,728
-21% -$59.2M 0.06% 452
2021
Q2
$259M Sell
2,297,744
-733,988
-24% -$77.3M 0.06% 390
2021
Q1
$289M Buy
3,031,732
+98,900
+3% +$9.02M 0.08% 324
2020
Q4
$233M Buy
2,932,832
+92,744
+3% +$6.72M 0.07% 369
2020
Q3
$176M Sell
2,840,088
-604,556
-18% -$39.3M 0.06% 407
2020
Q2
$227M Buy
3,444,644
+735,476
+27% +$44M 0.08% 290
2020
Q1
$128M Sell
2,709,168
-1,441,256
-35% -$72.1M 0.05% 419
2019
Q4
$228M Buy
4,150,424
+85,068
+2% +$4.46M 0.07% 353
2019
Q3
$199M Sell
4,065,356
-191,428
-4% -$9.6M 0.05% 423
2019
Q2
$222M Buy
4,256,784
+2,096,864
+97% +$106M 0.06% 390
2019
Q1
$107M Sell
2,159,920
-54,888
-2% -$2.47M 0.04% 512
2018
Q4
$80.1M Sell
2,214,808
-502,876
-19% -$21M 0.03% 552
2018
Q3
$139M Sell
2,717,684
-80,072
-3% -$3.55M 0.04% 453
2018
Q2
$103M Buy
2,797,756
+109,216
+4% +$4.17M 0.03% 538
2018
Q1
$102M Sell
2,688,540
-80,324
-3% -$2.84M 0.04% 478
2017
Q4
$89.7M Sell
2,768,864
-213,592
-7% -$6.79M 0.03% 534
2017
Q3
$90.1M Buy
2,982,456
+436,428
+17% +$13M 0.03% 548
2017
Q2
$74.8M Buy
2,546,028
+191,132
+8% +$5.22M 0.02% 600
2017
Q1
$59.8M Sell
2,354,896
-1,095,212
-32% -$28.3M 0.02% 699
2016
Q4
$88.7M Sell
3,450,108
-9,348
-0.3% -$246K 0.03% 557
2016
Q3
$94.7M Sell
3,459,456
-278,096
-7% -$7.64M 0.03% 531
2016
Q2
$105M Sell
3,737,552
-9,284
-0.2% -$239K 0.04% 485
2016
Q1
$88.5M Sell
3,746,836
-41,636
-1% -$917K 0.04% 543
2015
Q4
$85.2M Buy
3,788,472
+692
+0% +$15.8K 0.03% 566
2015
Q3
$87.6M Buy
3,787,780
+1,660
+0% +$41.6K 0.04% 522
2015
Q2
$93.2M Buy
3,786,120
+19,304
+0.5% +$482K 0.04% 546
2015
Q1
$94.4M Sell
3,766,816
-598,484
-14% -$14.2M 0.04% 537
2014
Q4
$101M Buy
4,365,300
+75,444
+2% +$1.73M 0.04% 514
2014
Q3
$100M Buy
4,289,856
+1,421,104
+50% +$33.3M 0.04% 508
2014
Q2
$66.4M Sell
2,868,752
-218,608
-7% -$4.83M 0.03% 664
2014
Q1
$65.9M Buy
3,087,360
+195,524
+7% +$4.4M 0.03% 657
2013
Q4
$68.4M Buy
2,891,836
+632,580
+28% +$13.7M 0.03% 657
2013
Q3
$45.2M Buy
2,259,256
+62,576
+3% +$1.19M 0.02% 809
2013
Q2
$37.9M Buy
+2,196,680
New +$36.5M 0.02% 840

Other funds holding TECH

Invesco's TECH Position: Q1 2026 in Review

Invesco increased its Bio-Techne (TECH) stake by 25% in Q1 2026, buying an estimated $54.6M and bringing the position to 4,588,706 shares worth $240M. The position accounts for 0.02% of the portfolio, ranked #631.

Invesco first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $289M in Q1 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Invesco held 4,588,706 shares of Bio-Techne worth $240M as of Q1 2026.
  • Invesco bought 910,047 Bio-Techne shares in Q1 2026, an estimated $54.6M.
  • Bio-Techne made up 0.02% of Invesco's portfolio in Q1 2026, its #631 holding.
  • Invesco first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Invesco's Bio-Techne position peaked at $289M in Q1 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.